Advanced search
1 file | 1.85 MB Add to list

Once-daily tiotropium and olodaterol fixed-dose combination via the respimat improves outcomes vs mono-components in COPD in two 1-year studies

(2015) RESPIROLOGY. 20(suppl. 2). p.77-77
Author
Organization

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.85 MB

Citation

Please use this url to cite or link to this publication:

MLA
Chia, M et al. “Once-daily Tiotropium and Olodaterol Fixed-dose Combination via the Respimat Improves Outcomes Vs Mono-components in COPD in Two 1-year Studies.” Respirology. Vol. 20. 2015. 77–77. Print.
APA
Chia, M., Reid, J., Buhl, R., Derom, E., Ferguson, G., Maltais, F., Pizzichini, E., et al. (2015). Once-daily tiotropium and olodaterol fixed-dose combination via the respimat improves outcomes vs mono-components in COPD in two 1-year studies. RESPIROLOGY (Vol. 20, pp. 77–77). Presented at the 2015 Annual scientific meeting of the Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science (TSANZSRS).
Chicago author-date
Chia, M, J Reid, R Buhl, Eric Derom, G Ferguson, F Maltais, E Pizzichini, et al. 2015. “Once-daily Tiotropium and Olodaterol Fixed-dose Combination via the Respimat Improves Outcomes Vs Mono-components in COPD in Two 1-year Studies.” In Respirology, 20:77–77.
Chicago author-date (all authors)
Chia, M, J Reid, R Buhl, Eric Derom, G Ferguson, F Maltais, E Pizzichini, H Watz, L Grönke, A Hamilton, K Tetzlaff, L Korducki, H Huisman, S Waitere-Wijker, and E Bateman. 2015. “Once-daily Tiotropium and Olodaterol Fixed-dose Combination via the Respimat Improves Outcomes Vs Mono-components in COPD in Two 1-year Studies.” In Respirology, 20:77–77.
Vancouver
1.
Chia M, Reid J, Buhl R, Derom E, Ferguson G, Maltais F, et al. Once-daily tiotropium and olodaterol fixed-dose combination via the respimat improves outcomes vs mono-components in COPD in two 1-year studies. RESPIROLOGY. 2015. p. 77–77.
IEEE
[1]
M. Chia et al., “Once-daily tiotropium and olodaterol fixed-dose combination via the respimat improves outcomes vs mono-components in COPD in two 1-year studies,” in RESPIROLOGY, Gold Coast, QLD, Australia, 2015, vol. 20, no. suppl. 2, pp. 77–77.
@inproceedings{6908582,
  articleno    = {abstract TP 038},
  author       = {Chia, M and Reid, J and Buhl, R and Derom, Eric and Ferguson, G and Maltais, F and Pizzichini, E and Watz, H and Grönke, L and Hamilton, A and Tetzlaff, K and Korducki, L and Huisman, H and Waitere-Wijker, S and Bateman, E},
  booktitle    = {RESPIROLOGY},
  issn         = {1323-7799},
  language     = {eng},
  location     = {Gold Coast, QLD, Australia},
  number       = {suppl. 2},
  pages        = {abstract TP 038:77--abstract TP 038:77},
  title        = {Once-daily tiotropium and olodaterol fixed-dose combination via the respimat improves outcomes vs mono-components in COPD in two 1-year studies},
  url          = {http://dx.doi.org/10.1111/resp.12495},
  volume       = {20},
  year         = {2015},
}

Altmetric
View in Altmetric
Web of Science
Times cited: